Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...

Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

Sanofi licensed the antibody from Alopexx Pharmaceuticals, a precursor to the current biotech of the same name, in 2009 but faced challenges such as the slow enrollment (PDF) of a phase 2a trial.

Proxima Fusion, a two-year-old German nuclear fusion startup, has published plans for a working fusion power plant in a peer-reviewed journal, in what is being touted as an important change in ...

Ankle fusion is a type of surgery to fuse the bones of your ankle into one piece. It’s also called ankle arthrodesis. The surgery is often done to treat arthritis in the ankle. The ankle joint is also ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that provide a clearer look at how the Teva-partnered prospect compares to Merck ...

View all available purchase options and get full access to this article. Supported by Damon Runyon Foundation, V Foundation for Cancer Research, and Sabin Family Foundation (X.L.); NIH/NCI P30CA016672 ...

France's WEST fusion reactor has shattered a nuclear fusion record set by China just a few weeks ago, marking yet another small but significant step on the road toward near-limitless clean energy.

Image credit: Shutterstock / Leitenberger Photography. Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement ...